Budesonide orodispersible tablet (once-daily vs twice-daily dosing)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide orodispersible tablet (once-daily vs twice-daily dosing), covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE [Phase 3]